Librax
INDICATIONS
Based on a review of this drug by the National Academy of Sciences - National Research Council and/or other information, FDA has classified the indications as follows:
"Possibly" effective: as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.
Final classification of the less-than-effective indications requires further investigation.
DOSAGE AND ADMINISTRATION
Because of the varied individual responses to tranquilizers and anticholinergics, the optimum dosage of Librax varies with the diagnosis and response of the individual patient. The dosage, therefore, should be individualized for maximum beneficial effects. The usual maintenance dose is 1 or 2 capsules, 3 or 4 times a day administered before meals and at bedtime.
HOW SUPPLIED
Librax is available in green capsules, each containing 5 mg chlordiazepoxide hydrochloride (Librium) and 2.5 mg clidinium bromide (Quarzan):
- bottles of 100 (NDC 0140-0007-01)
- bottles of 500 (NDC 0140-0007-14).
REFERENCES
Generic Name: Chlordiazepoxide and Clidinium
IBS Trigger Foods
Everyone’s IBS is different, but something most sufferers have in common is symptom triggers. See more WebMD Videos »
GI Disorders
Get the latest treatment options.
